nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—Voacamine—Vinblastine—head and neck cancer	0.918	1	CrCrCtD
Rescinnamine—ACE—forelimb zeugopod—head and neck cancer	0.0062	0.479	CbGeAlD
Rescinnamine—Skin cancer—Hydroxyurea—head and neck cancer	0.0051	0.0734	CcSEcCtD
Rescinnamine—Tearing eyes—Docetaxel—head and neck cancer	0.00501	0.072	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.00266	0.0382	CcSEcCtD
Rescinnamine—Skin irritation—Fluorouracil—head and neck cancer	0.00263	0.0379	CcSEcCtD
Rescinnamine—Bullous eruption—Docetaxel—head and neck cancer	0.00208	0.0299	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.00191	0.0275	CcSEcCtD
Rescinnamine—Tingling sensation—Fluorouracil—head and neck cancer	0.00142	0.0204	CcSEcCtD
Rescinnamine—Stinging—Fluorouracil—head and neck cancer	0.00141	0.0202	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.00138	0.0199	CcSEcCtD
Rescinnamine—Eye irritation—Fluorouracil—head and neck cancer	0.00133	0.0192	CcSEcCtD
Rescinnamine—Lacrimation increased—Fluorouracil—head and neck cancer	0.00124	0.0178	CcSEcCtD
Rescinnamine—Redness—Docetaxel—head and neck cancer	0.00122	0.0175	CcSEcCtD
Rescinnamine—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.0012	0.0173	CcSEcCtD
Rescinnamine—Dermatitis contact—Fluorouracil—head and neck cancer	0.00113	0.0162	CcSEcCtD
Rescinnamine—ACE—mouth—head and neck cancer	0.00112	0.0866	CbGeAlD
Rescinnamine—Angina pectoris—Vinblastine—head and neck cancer	0.00106	0.0152	CcSEcCtD
Rescinnamine—Eye irritation—Docetaxel—head and neck cancer	0.000962	0.0138	CcSEcCtD
Rescinnamine—ACE—neck—head and neck cancer	0.000957	0.0741	CbGeAlD
Rescinnamine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000956	0.0138	CcSEcCtD
Rescinnamine—Myocardial infarction—Vinblastine—head and neck cancer	0.000951	0.0137	CcSEcCtD
Rescinnamine—Lacrimation increased—Docetaxel—head and neck cancer	0.000892	0.0128	CcSEcCtD
Rescinnamine—Hypoaesthesia—Vinblastine—head and neck cancer	0.000867	0.0125	CcSEcCtD
Rescinnamine—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000865	0.0124	CcSEcCtD
Rescinnamine—Pharyngitis—Vinblastine—head and neck cancer	0.000864	0.0124	CcSEcCtD
Rescinnamine—Angina pectoris—Fluorouracil—head and neck cancer	0.000696	0.01	CcSEcCtD
Rescinnamine—Erythema—Hydroxyurea—head and neck cancer	0.000691	0.00994	CcSEcCtD
Rescinnamine—ACE—connective tissue—head and neck cancer	0.000686	0.0531	CbGeAlD
Rescinnamine—SLC18A2—thyroid gland—head and neck cancer	0.000667	0.0516	CbGeAlD
Rescinnamine—Hypertension—Vinblastine—head and neck cancer	0.000655	0.00941	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000652	0.00938	CcSEcCtD
Rescinnamine—ACE—epithelium—head and neck cancer	0.000651	0.0504	CbGeAlD
Rescinnamine—Discomfort—Vinblastine—head and neck cancer	0.000638	0.00917	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000628	0.00903	CcSEcCtD
Rescinnamine—Myocardial infarction—Fluorouracil—head and neck cancer	0.000624	0.00898	CcSEcCtD
Rescinnamine—Dermatitis bullous—Docetaxel—head and neck cancer	0.000624	0.00898	CcSEcCtD
Rescinnamine—Urinary tract infection—Fluorouracil—head and neck cancer	0.000619	0.0089	CcSEcCtD
Rescinnamine—Conjunctivitis—Fluorouracil—head and neck cancer	0.000619	0.0089	CcSEcCtD
Rescinnamine—Sinusitis—Fluorouracil—head and neck cancer	0.000597	0.00859	CcSEcCtD
Rescinnamine—SLC18A2—head—head and neck cancer	0.000592	0.0458	CbGeAlD
Rescinnamine—Discomfort—Hydroxyurea—head and neck cancer	0.000582	0.00837	CcSEcCtD
Rescinnamine—Rhinitis—Fluorouracil—head and neck cancer	0.000573	0.00824	CcSEcCtD
Rescinnamine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000569	0.00818	CcSEcCtD
Rescinnamine—Pharyngitis—Fluorouracil—head and neck cancer	0.000567	0.00816	CcSEcCtD
Rescinnamine—Oedema—Hydroxyurea—head and neck cancer	0.000564	0.00812	CcSEcCtD
Rescinnamine—Infection—Hydroxyurea—head and neck cancer	0.000561	0.00806	CcSEcCtD
Rescinnamine—Paraesthesia—Vinblastine—head and neck cancer	0.000556	0.00799	CcSEcCtD
Rescinnamine—Pain—Vinblastine—head and neck cancer	0.000529	0.00761	CcSEcCtD
Rescinnamine—Constipation—Vinblastine—head and neck cancer	0.000529	0.00761	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000506	0.00728	CcSEcCtD
Rescinnamine—Angina pectoris—Docetaxel—head and neck cancer	0.000502	0.00722	CcSEcCtD
Rescinnamine—ACE—lymphoid tissue—head and neck cancer	0.000502	0.0388	CbGeAlD
Rescinnamine—Erythema—Fluorouracil—head and neck cancer	0.000498	0.00716	CcSEcCtD
Rescinnamine—Abdominal pain—Vinblastine—head and neck cancer	0.000489	0.00704	CcSEcCtD
Rescinnamine—Pain—Hydroxyurea—head and neck cancer	0.000483	0.00694	CcSEcCtD
Rescinnamine—Constipation—Hydroxyurea—head and neck cancer	0.000483	0.00694	CcSEcCtD
Rescinnamine—Hypersensitivity—Vinblastine—head and neck cancer	0.000456	0.00656	CcSEcCtD
Rescinnamine—ACE—thyroid gland—head and neck cancer	0.000456	0.0353	CbGeAlD
Rescinnamine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000453	0.00652	CcSEcCtD
Rescinnamine—Myocardial infarction—Docetaxel—head and neck cancer	0.000451	0.00648	CcSEcCtD
Rescinnamine—Conjunctivitis—Docetaxel—head and neck cancer	0.000447	0.00643	CcSEcCtD
Rescinnamine—Myalgia—Fluorouracil—head and neck cancer	0.000424	0.00609	CcSEcCtD
Rescinnamine—Discomfort—Fluorouracil—head and neck cancer	0.000419	0.00602	CcSEcCtD
Rescinnamine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000416	0.00598	CcSEcCtD
Rescinnamine—SLC18A2—lymph node—head and neck cancer	0.000415	0.0321	CbGeAlD
Rescinnamine—Rhinitis—Docetaxel—head and neck cancer	0.000414	0.00595	CcSEcCtD
Rescinnamine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000411	0.00591	CcSEcCtD
Rescinnamine—Pharyngitis—Docetaxel—head and neck cancer	0.00041	0.00589	CcSEcCtD
Rescinnamine—Dizziness—Vinblastine—head and neck cancer	0.000409	0.00589	CcSEcCtD
Rescinnamine—Oedema—Fluorouracil—head and neck cancer	0.000406	0.00584	CcSEcCtD
Rescinnamine—ACE—head—head and neck cancer	0.000404	0.0313	CbGeAlD
Rescinnamine—Infection—Fluorouracil—head and neck cancer	0.000404	0.0058	CcSEcCtD
Rescinnamine—Headache—Vinblastine—head and neck cancer	0.000388	0.00558	CcSEcCtD
Rescinnamine—Dizziness—Hydroxyurea—head and neck cancer	0.000373	0.00537	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00037	0.00532	CcSEcCtD
Rescinnamine—Nausea—Vinblastine—head and neck cancer	0.000368	0.00529	CcSEcCtD
Rescinnamine—Insomnia—Fluorouracil—head and neck cancer	0.000367	0.00528	CcSEcCtD
Rescinnamine—Paraesthesia—Fluorouracil—head and neck cancer	0.000365	0.00525	CcSEcCtD
Rescinnamine—Erythema—Docetaxel—head and neck cancer	0.000359	0.00517	CcSEcCtD
Rescinnamine—Rash—Hydroxyurea—head and neck cancer	0.000356	0.00512	CcSEcCtD
Rescinnamine—Dermatitis—Hydroxyurea—head and neck cancer	0.000355	0.00511	CcSEcCtD
Rescinnamine—Headache—Hydroxyurea—head and neck cancer	0.000354	0.00508	CcSEcCtD
Rescinnamine—Dysgeusia—Docetaxel—head and neck cancer	0.000352	0.00506	CcSEcCtD
Rescinnamine—Back pain—Docetaxel—head and neck cancer	0.000347	0.005	CcSEcCtD
Rescinnamine—Pain—Fluorouracil—head and neck cancer	0.000347	0.005	CcSEcCtD
Rescinnamine—Nausea—Hydroxyurea—head and neck cancer	0.000335	0.00482	CcSEcCtD
Rescinnamine—Urticaria—Fluorouracil—head and neck cancer	0.000323	0.00464	CcSEcCtD
Rescinnamine—Cough—Docetaxel—head and neck cancer	0.000313	0.00451	CcSEcCtD
Rescinnamine—Hypertension—Docetaxel—head and neck cancer	0.00031	0.00446	CcSEcCtD
Rescinnamine—Myalgia—Docetaxel—head and neck cancer	0.000306	0.0044	CcSEcCtD
Rescinnamine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000299	0.0043	CcSEcCtD
Rescinnamine—Oedema—Docetaxel—head and neck cancer	0.000293	0.00422	CcSEcCtD
Rescinnamine—Infection—Docetaxel—head and neck cancer	0.000291	0.00419	CcSEcCtD
Rescinnamine—Pruritus—Fluorouracil—head and neck cancer	0.000287	0.00413	CcSEcCtD
Rescinnamine—ACE—lymph node—head and neck cancer	0.000283	0.0219	CbGeAlD
Rescinnamine—Dizziness—Fluorouracil—head and neck cancer	0.000269	0.00386	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000267	0.00384	CcSEcCtD
Rescinnamine—Insomnia—Docetaxel—head and neck cancer	0.000265	0.00381	CcSEcCtD
Rescinnamine—Paraesthesia—Docetaxel—head and neck cancer	0.000263	0.00379	CcSEcCtD
Rescinnamine—Rash—Fluorouracil—head and neck cancer	0.000256	0.00368	CcSEcCtD
Rescinnamine—Dermatitis—Fluorouracil—head and neck cancer	0.000256	0.00368	CcSEcCtD
Rescinnamine—Headache—Fluorouracil—head and neck cancer	0.000254	0.00366	CcSEcCtD
Rescinnamine—Constipation—Docetaxel—head and neck cancer	0.000251	0.00361	CcSEcCtD
Rescinnamine—Pain—Docetaxel—head and neck cancer	0.000251	0.00361	CcSEcCtD
Rescinnamine—Nausea—Fluorouracil—head and neck cancer	0.000241	0.00347	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00024	0.00345	CcSEcCtD
Rescinnamine—Abdominal pain—Docetaxel—head and neck cancer	0.000232	0.00333	CcSEcCtD
Rescinnamine—Hypersensitivity—Docetaxel—head and neck cancer	0.000216	0.00311	CcSEcCtD
Rescinnamine—Pruritus—Docetaxel—head and neck cancer	0.000207	0.00298	CcSEcCtD
Rescinnamine—Dizziness—Docetaxel—head and neck cancer	0.000194	0.00279	CcSEcCtD
Rescinnamine—Rash—Docetaxel—head and neck cancer	0.000185	0.00266	CcSEcCtD
Rescinnamine—Dermatitis—Docetaxel—head and neck cancer	0.000185	0.00266	CcSEcCtD
Rescinnamine—Headache—Docetaxel—head and neck cancer	0.000184	0.00264	CcSEcCtD
Rescinnamine—Nausea—Docetaxel—head and neck cancer	0.000174	0.0025	CcSEcCtD
